Skip to main content
Clinical Trials/NCT05009771
NCT05009771
Recruiting
Not Applicable

Postoperative Pain Management of Caesarean Section: a Prospective, Observational Cohort Study

Mackay Memorial Hospital2 sites in 1 country100 target enrollmentFebruary 23, 2022

Overview

Phase
Not Applicable
Intervention
Intravenous patient-control analgesia
Conditions
Postoperative Pain
Sponsor
Mackay Memorial Hospital
Enrollment
100
Locations
2
Primary Endpoint
Postpartum pain intensity
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

Caesarean section is one of the most frequent surgeries causing severe postoperative pain. Poor management of acute pain can contribute to postoperative complications, late recovery and the development of chronic pain. Moreover, it had been demonstrated that the intensity of postpartum pain is associated with depression. It is imperative to find out appropriate methods of postpartum pain alleviation. Currently, a lot of analgesic drugs and methods have been developed and used in clinical practice, such as patient-controlled analgesia, extended-release analgesics and multimodal analgesia. This prospective cohort study is aimed to investigate the outcome of each postoperative analgesic method used in caesarean section.

Detailed Description

This is a prospective, observational, cohort study. Patients undergoing elective caesarean section will be invited to the study. The written informed consent will be obtained prior to participation. After getting the written informed consent, data will be collected from medical records, questionnaires, patient diaries, visit records and telephone visit records. Through telephone visits, postpartum depression scale and postpartum chronic pain will be evaluated six weeks and three months after delivery. Demographic data, consumption of analgesics, analgesic methods, intensity of postoperative pain, complications, recovery time, score of depression scale will all be summarized. Numerical variables will be present with mean and standard deviation and categorical variables will be present with number and percentage.

Registry
clinicaltrials.gov
Start Date
February 23, 2022
End Date
July 31, 2026
Last Updated
11 months ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chi-Hsu Wang

Principal Investigator

Mackay Memorial Hospital

Eligibility Criteria

Inclusion Criteria

  • Planing to undergo caesarean section with spinal anesthesia.
  • Scheduled to undergo cesarean section between 37 and 40 weeks of gestation.
  • American Society of Anesthesiology Physical Class 1-
  • Planing to alleviate postoperative pain with intravenous patient-controlled analgesia or administration of NALDEBAIN.

Exclusion Criteria

  • Not willing to provide informed consent.
  • Unable to receive opioids or NSAIDs due to contraindication.
  • Long-term use of opioids or drug abuse.
  • Suffering from chronic pain disease.
  • Having medical history of mental illnesses.
  • Diagnosed with Pre-eclampsia or eclampsia.
  • Diagnosed with gestational diabetes.
  • Unsuitable for participation judged by investigator.

Arms & Interventions

IV-PCA + NALDEBAIN group

Patients treated with the combination of IV-PCA and intramuscular injection of dinalbuphine sebacate will be allocated to IV-PCA + NALDEBAIN group.

Intervention: Intravenous patient-control analgesia

IV-PCA + NALDEBAIN group

Patients treated with the combination of IV-PCA and intramuscular injection of dinalbuphine sebacate will be allocated to IV-PCA + NALDEBAIN group.

Intervention: Dinalbuphine sebacate

IV-PCA group

Patients receiving intravenous patient-controlled analgesia (IV-PCA) will be allocated to IV-PCA group.

Intervention: Intravenous patient-control analgesia

Outcomes

Primary Outcomes

Postpartum pain intensity

Time Frame: Within 5 days after delivery

Pain intensity is assessed by numerical rating scale (NRS) at least twice daily during hospital stay after delivery. NRS is a 11-point scale which labeled from zero (no pain) to ten (worst pain). The area under the curve of NRS are calculated.

Secondary Outcomes

  • Consumption of analgesics(Within 5 days after delivery)
  • Breastfeeding(Up to 5 days after delivery)
  • Satisfaction assessed by a four-point scale(6 weeks after delivery)
  • Ambulation(Up to 5 days after delivery)
  • Incidence of complications(Up to 5 days after delivery)
  • Gastrointestinal function recovery(Up to 5 days after delivery)
  • Postnatal Depression assessment(At baseline, 6 weeks and 3 months after delivery)
  • Chronic pain intensity(6 weeks and 3 months after delivery)

Study Sites (2)

Loading locations...

Similar Trials